MedEsthetics
OCTOBER 24, 2024
TEOXANE, a Swiss-based skin care brand known for its advanced, science-driven anti-aging and skin rejuvenating products, is set to launch in the U.S. January 2025.
Dermatology Times
OCTOBER 24, 2024
Among the many sessions to be held at the Fall Clinical Dermatology Conference in Las Vegas, Nevada, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Starpil Wax
OCTOBER 24, 2024
If you're new to waxing or considering switching from another hair removal method, you might be wondering, "How long does waxing actually last?" The answer isn't as straightforward as you might think, but understanding the basics of hair growth can help you get the most out of your waxing sessions. Table of Contents Areas of Waxing How Long Does Waxing Typically Last?
Dermatology Times
OCTOBER 24, 2024
Survey results presented at ACAAI’s annual Scientific Meeting demonstrate the limited influence of elimination diets for reducing symptoms of AD.
Beauty Launchpad
OCTOBER 24, 2024
A passionate educator and salon owner has swept to victory in the $28,000 Vish Color Bar Makeover Giveaway, with her and her team winning a personalized color bar from Minerva Beauty, an inventory restock and the gift of Vish.
Dermatology Times
OCTOBER 24, 2024
Del Rosso reviews numerous new and upcoming topical therapeutics and indications including ruxolitinib, tapinarof, and more.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
OCTOBER 24, 2024
Catch up on coverage from the first day of the 2024 Fall Clinical Dermatology Conference in Las Vegas, Nevada.
MedEsthetics
OCTOBER 24, 2024
New distribution partnership and powerful integrations expand the way sellers discover and use Square.
Dermatology Times
OCTOBER 24, 2024
The conference aimed at providing dermatology clinicians with the latest in the specialty begins today in Las Vegas, Nevada.
Mindbody
OCTOBER 24, 2024
Another month, another round of improvements! This month’s updates include appointment optimizations, new class booking windows, and more.
Dermatology Times
OCTOBER 24, 2024
The conference will feature presentations on a number of disease states, therapeutic options, and new clinical data.
Mindbody
OCTOBER 24, 2024
Another month, another round of improvements! This month’s updates include appointment optimizations, new class booking windows, and more.
Dermatology Times
OCTOBER 24, 2024
Share with us the topics you want to learn more about at Fall Clinical.
Skin Inc
OCTOBER 24, 2024
For more context on this up-and-coming trend and how spas can embrace this concept in their services, we chatted with Kathleen Hamilton, regional trainer and education director at Woodhouse Spa.
Dermatology Times
OCTOBER 24, 2024
Clinicians presented a panel-style session at Fall Clinical, touching on the drawbacks of topical steroid use and alternatives in AD patients.
The Dermatology Digest
OCTOBER 24, 2024
Patients can treat their psoriasis as well at home using phototherapy devices as they can with narrowband ultraviolet B (nbUVB) phototherapy administered in the clinic, according to Results of the LITE study (Light Treatment Effectiveness study) in JAMA Dermatology. Fully 60% of patients who followed the recommended light therapy course twice a week at home or in a clinic had clear or mostly clear skin after 12 weeks of treatment, but patients who received at-home treatment were more likely to
Fairlawn Aesthetic MD
OCTOBER 24, 2024
In the dynamic world of aesthetic treatments, Radiofrequency Microneedling is rapidly emerging as a revolutionary technique for rejuvenating the skin. This advanced procedure offers a multitude of benefits, from reducing wrinkles to enhancing skin texture. Let’s explore what makes RF Microneedling such a groundbreaking option for those seeking effective skin rejuvenation.
The Dermatology Digest
OCTOBER 24, 2024
Apogee Therapeutics, Inc. APG777 continues to show promise in atopic dermatitis (AD), according to early data. APG777 is a novel half-life extended anti-interleukin (IL)-13 antibody under development for the treatment for AD and other inflammatory diseases. Pharmacokinetic data up to 9 months show a half-life of approximately 75 days, approximately three to five times that of currently approved treatments for moderate-to-severe AD. near-complete inhibition of pSTAT6 and sustained TARC inhibition
Skin Inc
OCTOBER 24, 2024
New distribution partnership and powerful integrations expand the way sellers discover and use Square.
The Dermatology Digest
OCTOBER 24, 2024
Roflumilast cream 0.15% (Zoryve, Arcutis) rapidly decreases the impact of atopic dermatitis (AD), including sleep loss and daily activities, on patients, families, and caregivers, according to data presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2024 Annual Scientific Meeting in Boston, MA. Roflumilast cream 0.15% also resulted in significant improvements across all efficacy endpoints, including validated Investigator Global Assessment-Atopic Dermatitis (vIGA-AD) Succ
Beauty Launchpad
OCTOBER 24, 2024
New distribution partnership and powerful integrations expand the way sellers discover and use Square.
Dermatology Times
OCTOBER 24, 2024
Findings from 2 phase 3 trials indicate that ZORYVE cream significantly improves both clinical outcomes and quality of life in patients with mild to moderate atopic dermatitis.
Dermatology Times
OCTOBER 24, 2024
The late-breaking data will be presented at ACAAI’s annual Scientific Meeting.
Expert insights. Personalized for you.
78 
Let's personalize your content